Accent Capital Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.4K Buy
1,412
+46
+3% +$1.46K 0.02% 119
2026
Q1
$43K Buy
1,366
+703
+106% +$22.1K 0.02% 115
2025
Q4
$19.5K Hold
663
0.01% 142
2025
Q3
$16.7K Sell
663
-252
-28% -$6.14K 0.01% 165
2025
Q2
$22K Hold
915
0.01% 158
2025
Q1
$21K Hold
915
0.01% 158
2024
Q4
$23.2K Hold
915
0.01% 108
2024
Q3
$22.8K Hold
915
0.01% 125
2024
Q2
$27.1K Buy
915
+202
+28% +$5.6K 0.02% 120
2024
Q1
$21.5K Hold
713
0.02% 98
2023
Q4
$20.4K Buy
+713
New +$20.9K 0.02% 130

Other funds holding RTO

Accent Capital Management's RTO Position: Q2 2026 in Review

Accent Capital Management increased its Rentokil (RTO) stake by 3.4% in Q2 2026, buying an estimated $1.46K and bringing the position to 1,412 shares worth $40.4K. The position accounts for 0.02% of the portfolio, ranked #119.

Accent Capital Management first reported a position in RTO in Q4 2023 and has held it in 11 quarters since. The position peaked at $43K in Q1 2026. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Accent Capital Management held 1,412 shares of Rentokil worth $40.4K as of Q2 2026.
  • Accent Capital Management bought 46 Rentokil shares in Q2 2026, an estimated $1.46K.
  • Rentokil made up 0.02% of Accent Capital Management's portfolio in Q2 2026, its #119 holding.
  • Accent Capital Management first reported a position in Rentokil in Q4 2023 and has held it in 11 quarters since.
  • Accent Capital Management's Rentokil position peaked at $43K in Q1 2026.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.